anonymous
Guest
anonymous
Guest
I just heard Pelacarsen will be delayed an additional year minimum. Can anyone confirm? If so, CV is definitely toast!
Being a part of the J&J situation, no one saw that coming. Sure the patent was running out of time but it didn’t necessitate dissolving the entire division. No warning at all. My best advice is to always be ready.J&J just laid off entire cardiovascular side of business. Xarelto has more time left on their patent than Entresto does. We should all be looking for other opportunities.